We recommend to make use of MetaStat fundamental analysis to find out if markets are presently mispricing the entity. Strictly speaking this technique allows you to check out available financial ratios of MetaStat as well as the relationship between them. We are able to interpolate and collect thirty-one available fundamentals for MetaStat, which can be compared to its peers in the industry. The stock experiences a normal downward fluctuation but is a risky buy. Check odds of MetaStat to be traded at $6.0E-4 in 90 days.
MetaStat
Please note, the imprecision that can be found in MetaStat's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of MetaStat. Check MetaStat's Beneish M Score to see the likelihood of MetaStat's management manipulating its earnings.
MetaStat Stock Summary
MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The companys therapeutic targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. MICROTEST INC operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 6 people.
MetaStat's financial ratios allow both analysts and investors to convert raw data from MetaStat's financial statements into concise, actionable information that can be used to evaluate the performance of MetaStat over time and compare it to other companies across industries.
Comparative valuation techniques use various fundamental indicators to help in determining MetaStat's current stock value. Our valuation model uses many indicators to compare MetaStat value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MetaStat competition to find correlations between indicators driving MetaStat's intrinsic value. More Info.
MetaStat is rated below average in return on asset category among its peers. It also is rated below average in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MetaStat's earnings, one of the primary drivers of an investment's value.
MetaStat January 17, 2026 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of MetaStat help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of MetaStat. We use our internally-developed statistical techniques to arrive at the intrinsic value of MetaStat based on widely used predictive technical indicators. In general, we focus on analyzing MetaStat Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build MetaStat's daily price indicators and compare them against related drivers.
When running MetaStat's price analysis, check to measure MetaStat's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetaStat is operating at the current time. Most of MetaStat's value examination focuses on studying past and present price action to predict the probability of MetaStat's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetaStat's price. Additionally, you may evaluate how the addition of MetaStat to your portfolios can decrease your overall portfolio volatility.